Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

InSilico Medicine Cayman TopCo

Market Cap: HK$22.6b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

Bonesupport Holding

Market Cap: SEK 14.7b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Tecan Group

Market Cap: CHF 2.3b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Natera

Market Cap: US$45.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €200.9m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

AstraZeneca

Market Cap: UK£183.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

CanSino Biologics

Market Cap: HK$10.2b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Almirall

Market Cap: €2.3b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Hyphens Pharma International

Market Cap: S$114.3m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

Xeris Biopharma Holdings

Market Cap: US$1.6b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Pangaea Oncology

Market Cap: €55.7m

A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

Renata

Market Cap: ৳53.8b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.

Mesoblast

Market Cap: AU$3.1b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Teva Pharmaceutical Industries

Market Cap: US$42.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Bora Pharmaceuticals

Market Cap: NT$51.6b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Galderma Group

Market Cap: CHF 39.5b

Operates as a dermatology company worldwide.

AbbVie

Market Cap: US$442.4b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.8b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Innovent Biologics

Market Cap: HK$171.0b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Aroa Biosurgery

Market Cap: AU$200.6m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Chugai Pharmaceutical

Market Cap: JP¥11.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Sotera Health

Market Cap: US$5.4b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

hVIVO

Market Cap: UK£45.3m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$58.1b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Ligand Pharmaceuticals

Market Cap: US$5.8b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

BioGaia

Market Cap: SEK 11.7b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Merck

Market Cap: US$333.5b

Operates as a healthcare company worldwide.

Selvita

Market Cap: zł513.0m

Provides drug discovery, drug development, and contract testing services in Poland.

Strides Pharma Science

Market Cap: ₹88.3b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

Viyash Scientific

Market Cap: ₹118.7b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

WuXi XDC Cayman

Market Cap: HK$86.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

L&C BIOLTD

Market Cap: ₩1.4t

Operates as a research and development company in tissue regeneration medicine.